Virinchi Ltd Allots 86 Lakh Warrants to Vivo Bio Tech at ₹28
Virinchi Limited has allotted 86,00,000 convertible equity warrants to Vivo Bio Tech Limited at ₹28 per warrant. The allotment follows shareholder approval and regulatory in-principle approvals. Warrants are convertible into equity shares within 18 months upon receipt of the balance subscription amount.
The allotment of warrants, especially to a promoter group entity, signifies a potential future increase in share capital and a shift in shareholding patterns. This can impact market perception and future capital structure, warranting a medium impact.
The announcement details the allotment of warrants, which is a step towards potential future equity dilution. While it secures funding and strengthens promoter group holding, the immediate impact is neutral as it does not represent immediate revenue or profit generation.
Virinchi Limited announced the allotment of 86,00,000 (Eighty-Six Lakh) convertible equity warrants to Vivo Bio Tech Limited, a promoter group entity. The allotment was approved by the Stakeholders Relationship Committee at a meeting held on Thursday, January 08, 2026. These warrants were issued on a preferential basis at an issue price of ₹28 per warrant, consisting of a face value of ₹10 and a premium of ₹18. The company received 25% of the issue price, amounting to ₹7 per warrant, upon allotment.
The issuance of these warrants follows a special resolution passed by shareholders at an Extra-Ordinary General Meeting on Saturday, November 15, 2025, and received in-principle approval from BSE and NSE on December 31, 2025. The remaining 75% of the issue price (₹21 per warrant) is to be received for the conversion of each warrant into one fully paid-up equity share. The warrants have a tenure of 18 months from the date of allotment for conversion.
Post this allotment, the total share capital of the company remains unchanged. However, assuming the conversion of these warrants, the shareholding pattern indicates an increase in the Promoter and Promoter Group's stake from 37.51% to 42.34%, while the Public shareholding would decrease from 62.49% to 57.66%. The total number of shares post-issue is expected to be 11,12,46,896.
What to do with a filing like this
Virinchi Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Virinchi Limited. Read the original for the full detail.